Commenting on the product launch, Mr. Sanjeev I. Dani, Regional Director, India operations, Ranbaxy, said, "Introduction of Forzest will provide Indian doctors with best-in-class and contemporary therapeutic option for management of Erectile Dysfunction, which also gives greater time window to the patients".

Ranbaxy Laboratories Limited, India's largest Rx pharmaceutical company, manufactures and markets branded generic drugs and Active Pharmaceutical Ingredients. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. Ranbaxy's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies" resulting in a number of products under development. The Company is selling its products in over 100 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 34 countries and manufacturing operations in 7 countries.